BioSpace News Archive

Medifocus Inc. (TSXV-MFS) (“ Medifocus ” or the “ Company ”) today announced in accordance with Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements of the Ontario Securities Commission (the “ Exemption Order ”), which was adopted for the purpose of providing certain filing and other relief to issuers in light of the challenges posted by the COVID-19 pandemic, that it will be delaying the filing of certain of its

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy, today announced that it received written communication from the U.S. Food and Drug Administration (FDA) that the Company’s IGNITE DMD Phase I/II clinical trial remains on clinical hold. In November 2019, the FDA placed IGNITE DMD on clinical hold as the result of a serious adverse event (SAE) that occurre

Advanced semiconductor-based DNA synthesis platform creates precise mutant libraries for engineering antibodies for in vitro diagnostic applications

Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement today warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies working to eradicate COVID-19 and lead to less patient access to lifesaving treatments.

The Public Health Agency of Canada is collaborating with provincial public health partners, the Canadian Food Inspection Agency, and Health Canada to investigate an outbreak of Salmonella infections occurring in five provinces.

Arrowhead Pharmaceuticals Inc. announced that as an inducement to entering into employment with the Company, on June 18, 2020, the Compensation Committee of the Board of Directors approved “inducement” grants to 25 new employees under Rule 5635 of the NASDAQ Marketplace Rules.